DUBLIN–(BUSINESS WIRE)–The “China Percutaneous Coronary Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook” report has been added to ResearchAndMarkets.com’s offering.
Why Buy This Report
- First-ever syndicated report with robust insights from Interventional Cardiologists and Cardiologists
- Helps in understanding the current market scenario of the percutaneous coronary interventions in China
- Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
- Valuable insights from demand side of the market
- Keep up with the latest market trends and novel technologies
Identify key players, local players and emerging players in the market
- Boston Scientific
- Medtronic
- Cordis
- B.Braun
- Shockwave Medical
- Philips
- Terumo
- BD/Bard
- Concept Medical
- OrbusNeich
- Microport Scientific
- JW Medical
- Genoss
- Shanghai Bio-heart biological Technology Co
- Elixir Medical Corporation
- Abbott
- Sinomed
- Kossel MedTech
- Biosensors International
- Lepu Medical
- LifeTech Scientific
Key Topics Covered:
RESEARCH PROCESS OVERVIEW
- Detailed Research Methodology
- Desk Research and Quantitative Research
EXECUTIVE SUMMARY
PERCUTANEOUS CORONARY INTERVENTION (PCI) CHINA MARKET OVERVIEW
- Market Background – What is the scope of the research?
I – HEALTHCARE INFRASTRUCTURE (PROVIDER)
- Healthcare Delivery Structure
- Cardiac Catheterization and Chest Pain Centres (CPC) in China
- Chest Pain Centers (CPC) – Impact on Diagnosis and Treatment
- Healthcare Infrastructure – Digital Health Technology (DHT)
- Healthcare Infrastructure Challenges
- Percutaneous Coronary Intervention – Access Point
II – PROCEDURE INSIGHTS
- Procedure Split by Facility Type
- Procedure Split by Imaging Type
- Procedure Split by Device Type
- Procedure Split by Techniques
- Procedure Split by Intervention Type
- Procedure Growth Rates
III – BRAND PERCEPTION
- Brand Perception (Interventionalists)
- Best-in-Class Brands
IV – COMPETITIVE INTELLIGENCE
- CI Snapshot
- Key Competitor Activities
- Product portfolio
- Product Approval Overview
- Clinical Trials Overview
- Company Profile
- Product Approvals
- Clinical Trials
- Partnerships, M&A, Collaborations
- Key Market Activities
- Major Adverse Events
V – HEALTHCARE POLICY (PAYER)
- Medical Devices Regulatory Body
- Regulatory Approval Pathway
- Reimbursement landscape
- Disease Screening and Awareness Programs
- Health Insurance Coverage
- Digital Health Policy
VI – CLINICAL INTELLIGENCE (PHYSICIAN)
- Referral Pathway
- Treatment Overview
- Treatment Care Pathway
- Interventional Therapies
- Interventional Technology
- Healthcare Specialists (who are the Performing Physicians)
- Epidemiology
CONCLUSION
APPENDICES
For more information about this report visit https://www.researchandmarkets.com/r/kd6x51.
The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
